{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:38:41Z","timestamp":1793093921760,"version":"4.5.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Santen Pharmaceuticals Co., Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s12325-025-03227-2","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T03:12:20Z","timestamp":1749525140000},"page":"3810-3825","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Study of 24-h Efficacy and Safety of Sepetaprost vs. Latanoprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension"],"prefix":"10.1007","volume":"42","author":[{"given":"Anastasios-Georgios","family":"Konstas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Garh\u00f6fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"L\u00fcbke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogomil","family":"Voykov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5603-9020","authenticated-orcid":false,"given":"Auli","family":"Ropo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"issue":"11","key":"3227_CR1","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1007\/s12325-018-0812-z","volume":"35","author":"AG Konstas","year":"2018","unstructured":"Konstas AG, Kahook MY, Araie M, et al. Diurnal and 24-h intraocular pressures in glaucoma: monitoring strategies and impact on prognosis and treatment. Adv Ther. 2018;35(11):1775\u2013804. https:\/\/doi.org\/10.1007\/s12325-018-0812-z.","journal-title":"Adv Ther"},{"key":"3227_CR2","doi-asserted-by":"publisher","first-page":"3632197","DOI":"10.1155\/2019\/3632197","volume":"2019","author":"CH Ho","year":"2019","unstructured":"Ho CH, Wong JKW. Role of 24-hour intraocular pressure monitoring in glaucoma management. J Ophthalmol. 2019;2019:3632197. https:\/\/doi.org\/10.1155\/2019\/3632197.","journal-title":"J Ophthalmol"},{"issue":"1","key":"3227_CR3","doi-asserted-by":"publisher","first-page":"P30","DOI":"10.1016\/j.ophtha.2020.10.021","volume":"128","author":"SJ Gedde","year":"2021","unstructured":"Gedde SJ, Chen PP, Muir KW, et al. Primary angle-closure disease Preferred Practice Pattern\u00ae. Ophthalmology. 2021;128(1):P30\u201370. https:\/\/doi.org\/10.1016\/j.ophtha.2020.10.021.","journal-title":"Ophthalmology"},{"issue":"3","key":"3227_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ajo.2004.04.022","volume":"138","author":"JH Liu","year":"2004","unstructured":"Liu JH, Kripke DF, Weinreb RN. Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure. Am J Ophthalmol. 2004;138(3):389\u201395. https:\/\/doi.org\/10.1016\/j.ajo.2004.04.022.","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"3227_CR5","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.ophtha.2007.10.004","volume":"115","author":"WC Stewart","year":"2008","unstructured":"Stewart WC, Konstas AG, Nelson LA, Kruft B. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines. Ophthalmology. 2008;115(7):1117\u201322. https:\/\/doi.org\/10.1016\/j.ophtha.2007.10.004.","journal-title":"Ophthalmology"},{"issue":"6","key":"3227_CR6","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.ajo.2006.01.049","volume":"141","author":"AJ Sit","year":"2006","unstructured":"Sit AJ, Weinreb RN, Crowston JG, Kripke DF, Liu JH. Sustained effect of travoprost on diurnal and nocturnal intraocular pressure. Am J Ophthalmol. 2006;141(6):1131\u20133. https:\/\/doi.org\/10.1016\/j.ajo.2006.01.049.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"3227_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-001106","volume":"2","author":"JD Tung","year":"2012","unstructured":"Tung JD, Tafreshi A, Weinreb RN, et al. Twenty-four-hour effects of bimatoprost 0.01% monotherapy on intraocular pressure and ocular perfusion pressure. BMJ Open. 2012;2(4):e001106. https:\/\/doi.org\/10.1136\/bmjopen-2012-001106.","journal-title":"BMJ Open"},{"key":"3227_CR8","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/eye.2012.195","volume":"26","author":"K Inoue","year":"2012","unstructured":"Inoue K, Shiokawa M, Higa R, Sugahara M, et al. Adverse periocular reactions to five types of prostaglandin analogs. Eye. 2012;26:1465\u201372. https:\/\/doi.org\/10.1038\/eye.2012.195.","journal-title":"Eye"},{"key":"3227_CR9","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.2147\/OPTH.S63760","volume":"8","author":"JK Schmier","year":"2014","unstructured":"Schmier JK, Hulme-Lowe CK, Covert DW. Adjunctive therapy patterns in glaucoma patients using prostaglandin analogs. Clin Ophthalmol. 2014;8:1097\u2013104. https:\/\/doi.org\/10.2147\/OPTH.S63760.","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"3227_CR10","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1089\/jop.2021.0077","volume":"38","author":"DL Wirta","year":"2022","unstructured":"Wirta DL, Kuwayama Y, Lu F, Shao H, Odani-Kawabata N. Phase\u00a02b, randomized, 3-month, dose-finding study of sepetaprost in patients with primary open-angle glaucoma or ocular hypertension: the ANGEL study. J Ocul Pharmacol Ther. 2022;38(3):240\u201351. https:\/\/doi.org\/10.1089\/jop.2021.0077.","journal-title":"J Ocul Pharmacol Ther"},{"key":"3227_CR11","unstructured":"National Institute for Health and Care Excellence. Treatment summaries: glaucoma and ocular hypertension; 2022. https:\/\/bnf.nice.org.uk\/treatment-summaries\/glaucoma-and-ocular-hypertension\/. Accessed 15 Jan 2025."},{"issue":"1","key":"3227_CR12","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1111\/aos.12408","volume":"93","author":"L Agnifili","year":"2015","unstructured":"Agnifili L, Mastropasqua R, Frezzotti P, et al. Circadian intraocular pressure patterns in healthy subjects, primary open angle and normal tension glaucoma patients with a contact lens sensor. Acta Ophthalmol. 2015;93(1):e14-21. https:\/\/doi.org\/10.1111\/aos.12408.","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"3227_CR13","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s10384-021-00844-6","volume":"65","author":"M Aihara","year":"2021","unstructured":"Aihara M. Prostanoid receptor agonists for glaucoma treatment. Jpn J Ophthalmol. 2021;65(5):581\u201390. https:\/\/doi.org\/10.1007\/s10384-021-00844-6.","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"3227_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ophtha.2007.03.007","volume":"115","author":"AG Konstas","year":"2008","unstructured":"Konstas AG, Kozobolis VP, Tsironi S, et al. Comparison of the 24-hour intraocular pressure-lowering effects of latanoprost and dorzolamide\/timolol fixed combination after 2 and 6\u00a0months of treatment. Ophthalmology. 2008;115(1):99\u2013103. https:\/\/doi.org\/10.1016\/j.ophtha.2007.03.007.","journal-title":"Ophthalmology"},{"key":"3227_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.18865\/EthnDis-2024-6","volume":"35","author":"P Prot\u00e1sio","year":"2025","unstructured":"Prot\u00e1sio P, Almeida MDC, Maestri MK, et al. Exploring associations between race\/ethnicity and glaucoma prevalence in a multicenter Brazilian study: the ELSA-Brasil. Ethnicity Dis. 2025;35:27\u201334. https:\/\/doi.org\/10.18865\/EthnDis-2024-6.","journal-title":"Ethnicity Dis"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03227-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03227-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03227-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T19:02:22Z","timestamp":1754334142000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03227-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["3227"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03227-2","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Prof. Anastasios-Georgios Konstas: research funding from Allergan, Bayer, Omni Vision, Pharmathen, and Santen Pharmaceuticals Co., Inc; travel support and congress expenses from Vianex\u00a0and Zwitter; and honoraria from Allergan, Esteve Pharmaceuticals, Santen, Inc., and Vianex. Dr. Bogomil Voykov: grants from Aerie Pharmaceuticals Ireland Ltd.\u00a0and Santen Pharmaceuticals Co., Inc.; and speaker honorarium and consultancy fees from AbbVie Deutschland GmbH & Co. KG, Santen GmbH, and Novartis GmbH. Dr. Jan L\u00fcbke: received honoraria from Allergan\/AbbVie; speaker honorarium and consulting fees from AbbVie Deutschland GmbH & Co. KG\u00a0and Santen GmbH; and speaker honorarium from Glaukos, iStar medical, and Th\u00e9a Pharma. Dr. Gerhard Garh\u00f6fer: consultant for Apis, Boehringer Ingelheim, Croma, EyeD, Kiora, Novaliq, Panoptes, Redwood, Santen Pharmaceuticals Co., Inc., Sintetica, and Thea. Dr. Auli Ropo: an employee of Santen, Oy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was conducted in compliance with regulatory requirements provided by the following institutional review boards or independent ethics committees; the Faculty of Medicine at the Eberhard-Karls-University and the University Hospital T\u00fcbingen (reference number 193\/2021), Ethics Committee of the University of Freiburg and the University of Vienna (reference number 1229\/2021), Ethics Committee for the Province of Salzburg, and the Hellenic Republic Ministry of Health National Ethics Committee (reference number 34443\/2021), in accordance with the protocol, Good Clinical Practice, The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use International guidelines, and the Declaration of Helsinki. All participants provided written informed consent prior to their participation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}